Drug treatments for schizophrenia

被引：6

作者：

Adams, C

Wilson, P ^{[1
]}

Gilbody, S

Bagnall, AM

Lewis, R

机构：

[1] Univ York, NHS Ctr Reviews & Disseminat, York YO1 5DD, N Yorkshire, England

[2] Cochrane Schizophrenia Grp, Oxford, England

来源：

QUALITY IN HEALTH CARE | 2000年 / 9卷 / 01期

关键词：

D O I：

10.1136/qhc.9.1.73

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

[No abstract available]

引用

收藏

页码：73 / 79

页数：7

相关论文

共 61 条

[1] ADAMS CE, 1999, COCHRANE LIB
[2] ADDINGTON DE, 1993, CLIN THER, V15, P917
[3] Randomised controlled trials in Archives of General Psychiatry (1959-1995):: A prevalence study
Ahmed, I
Seifas, R
[J]. ARCHIVES OF GENERAL PSYCHIATRY, 1998, 55 (08) : 754 - 755
[4] Cost-effectiveness of clozapine - A UK clinic-based study
Aitchison, KJ
Kerwin, RW
[J]. BRITISH JOURNAL OF PSYCHIATRY, 1997, 171 : 125 - 130
[5] Cost analysis of the treatment of schizophrenia in the UK - A comparison of olanzapine and haloperidol
Almond, S
O'Donnell, O
[J]. PHARMACOECONOMICS, 1998, 13 (05) : 575 - 588
[6] CLOZAPINE-INDUCED AGRANULOCYTOSIS - INCIDENCE AND RISK-FACTORS IN THE UNITED-STATES
ALVIR, JMJ
LIEBERMAN, JA
SAFFERMAN, AZ
SCHWIMMER, JL
SCHAAF, JA
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (03) : 162 - 167
[7] [Anonymous], 1999, EFFECTIVE HLTH CARE, V5
[8] [Anonymous], 1986, POSITIVE NEGATIVE SY
[9] [Anonymous], 2018, REP TASK FORC DISS P
[10] [Anonymous], SYNOPSIS OF PSYCHIAT

← 1 2 3 4 5 6 7 →